← Back to Search

Thrombectomy Device

thrombectomy for Stroke (DELPHI EFS Trial)

N/A
Recruiting
Research Sponsored by University at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Summary

This trial is testing a new device to see if it is safe and effective at removing clots in stroke patients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate technical efficacy outcomes with radiographical measurements
outcomes with radiographical measurements

Trial Design

1Treatment groups
Experimental Treatment
Group I: Delphi Revascularization DeviceExperimental Treatment1 Intervention
Delphi Revascularization device is an investigational device. The device is itself a combination of SolitaireX™ Revascularization device and Artisse Detachment Device to apply 2mAmp constant current to the Solitaire device via ADD
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
thrombectomy
2017
N/A
~70

Find a Location

Who is running the clinical trial?

University at BuffaloLead Sponsor
132 Previous Clinical Trials
98,964 Total Patients Enrolled
2 Trials studying Stroke
318 Patients Enrolled for Stroke
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top